Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 2/3 1Phase 1/2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 9Breast 9Genitourinary 7Thoracic 6Gynecologic 5Lymphoid 3Classical hematology 3Other hematologic neoplasm 2Dermatologic 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Head & Neck 1CNS 1

Conditions

Lymphoma 2Pain, Postoperative 1Pain 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia, Lymphocytic, Chronic, B-Cell 1Bacterial Infections 1Agammaglobulinemia 1

Interventions

Rituximab 238Cyclophosphamide 192Vincristine 164Doxorubicin 150Prednisone 126Methotrexate 80Cytarabine 79Etoposide 78Dexamethasone 72Radiotherapy 60Bendamustine Hydrochloride 58Mercaptopurine 46Lenalidomide 42pegaspargase 41Prednisolone 38Filgrastim 38ibrutinib 37fludarabine 36Bleomycin 36Daunorubicin 35obinutuzumab 34Asparaginase 33Leucovorin 29venetoclax 28Granulocyte Colony-Stimulating Factor 28Chlorambucil 27Calcium Dobesilate 27Gemcitabine 26Vinblastine 25Thioguanine 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Saline Solution × Lymphoid × Clear all
NCT03823534 2026-04-22

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

St. Louis University

Phase 3 Recruiting
60 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Pain, Pain, Postoperative

NCT05645107 2026-04-13

EXCELL

Grifols Therapeutics LLC

Phase 3 Recruiting
386 enrolled
LymphoidOther hematologic neoplasm

Agammaglobulinemia, Bacterial Infections, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00583323 2014-08-21

Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET

Mayo Clinic

Phase 3 Completed
60 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡